Guranda Chitadze

902 total citations
23 papers, 667 citations indexed

About

Guranda Chitadze is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Guranda Chitadze has authored 23 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Guranda Chitadze's work include Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (10 papers) and T-cell and B-cell Immunology (4 papers). Guranda Chitadze is often cited by papers focused on Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (10 papers) and T-cell and B-cell Immunology (4 papers). Guranda Chitadze collaborates with scholars based in Germany, Austria and Czechia. Guranda Chitadze's co-authors include Dieter Kabelitz, Marcus Lettau, Ottmar Janßen, Jaydeep Bhat, Hans‐Heinrich Oberg, Daniela Wesch, Joannis Mytilineos, Daniel Fürst, Alexander Steinle and Holger Kalthoff and has published in prestigious journals such as Blood, Scientific Reports and International Journal of Cancer.

In The Last Decade

Guranda Chitadze

23 papers receiving 655 citations

Peers

Guranda Chitadze

IMMUN

ONCOL

GENET

Christian Sordo‐Bahamonde Spain

Seila Lorenzo‐Herrero Spain

Liliana E. Lucca United States

Kanutte Huse Norway

Shamaila Munir Ahmad Denmark

Jani Huuhtanen Finland

Hideo Komita Japan

Élodie Picarda France

Lequn Li United States

Marta Camoriano United States

Christian Sordo‐Bahamonde Spain

Guranda Chitadze

440 ×0.9

IMMUN

393 ×1.2

ONCOL

121 ×0.8

60 ×1.0

GENET

46 ×0.8

Citations per year, relative to Guranda Chitadze Guranda Chitadze (= 1×) peers Christian Sordo‐Bahamonde

Countries citing papers authored by Guranda Chitadze

Since Specialization

Citations

This map shows the geographic impact of Guranda Chitadze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guranda Chitadze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guranda Chitadze more than expected).

Fields of papers citing papers by Guranda Chitadze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guranda Chitadze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guranda Chitadze. The network helps show where Guranda Chitadze may publish in the future.

Co-authorship network of co-authors of Guranda Chitadze

This figure shows the co-authorship network connecting the top 25 collaborators of Guranda Chitadze. A scholar is included among the top collaborators of Guranda Chitadze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guranda Chitadze. Guranda Chitadze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Karow, Axel, Thomas Lion, Guranda Chitadze, et al.. (2024). CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase. Annals of Hematology. 103(11). 4811–4815. 2 indexed citations

Nimmerjahn, Falk, Eva Maria Murga Penas, Guranda Chitadze, et al.. (2024). A Novel Platform Technology for the Development of NK Cell-Based Cellular Immunotherapies. Blood. 144(Supplement 1). 914–914. 3 indexed citations

Kotrová, Michaela, Claudia D. Baldus, Marcus Lettau, et al.. (2023). Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?. HemaSphere. 7(9). e948–e948. 2 indexed citations

Chitadze, Guranda, et al.. (2022). A New View on Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia using Droplet Digital PCR. Journal of Molecular Diagnostics. 24(8). 856–866. 6 indexed citations

Kabelitz, Dieter, et al.. (2022). Signal strength of STING activation determines cytokine plasticity and cell death in human monocytes. Scientific Reports. 12(1). 17827–17827. 21 indexed citations

Chitadze, Guranda & Dieter Kabelitz. (2022). Immune surveillance in glioblastoma: Role of the NKG2D system and novel cell‐based therapeutic approaches. Scandinavian Journal of Immunology. 96(2). e13201–e13201. 17 indexed citations

Raatz, Michael, Saumil Shah, Guranda Chitadze, Monika Brüggemann, & Arne Traulsen. (2021). The impact of phenotypic heterogeneity of tumour cells on treatment and relapse dynamics. PLoS Computational Biology. 17(2). e1008702–e1008702. 11 indexed citations

Chitadze, Guranda, Ulrike Wehkamp, Ottmar Janßen, Monika Brüggemann, & Marcus Lettau. (2021). The Serine Protease CD26/DPP4 in Non-Transformed and Malignant T Cells. Cancers. 13(23). 5947–5947. 15 indexed citations

Chitadze, Guranda, et al.. (2020). Bispecific antibodies in acute lymphoblastic leukemia therapy. Expert Review of Hematology. 13(11). 1211–1233. 5 indexed citations

10.

Bhat, Jaydeep, Alexandra Dananberg, Elgar Susanne Quabius, et al.. (2019). Histone Deacetylase Inhibitor Modulates NKG2D Receptor Expression and Memory Phenotype of Human Gamma/Delta T Cells Upon Interaction With Tumor Cells. Frontiers in Immunology. 10. 569–569. 23 indexed citations

11.

Chitadze, Guranda, Anna Stengel, Heiko Trautmann, et al.. (2019). S129 TP53 SOMATIC MUTATIONS AS PRE‐LEUKEMIC EVENTS IN ACUTE LYMPHOBLASTIC LEUKEMIA. HemaSphere. 3(S1). 16–17. 1 indexed citations

12.

Hansen, Jan Hinnerk, Guranda Chitadze, Olaf Jung, et al.. (2019). Glial Fibrillary Acid Protein and Cerebral Oxygenation in Neonates Undergoing Cardiac Surgery. The Thoracic and Cardiovascular Surgeon. 67(S 04). e11–e18. 1 indexed citations

13.

Lettau, Marcus, et al.. (2019). Degranulation of human cytotoxic lymphocytes is a major source of proteolytically active soluble CD26/DPP4. Cellular and Molecular Life Sciences. 77(4). 751–764. 18 indexed citations

14.

Flüh, Charlotte, Guranda Chitadze, Kirsten Hattermann, et al.. (2018). NKG2D ligands in glioma stem-like cells: expression in situ and in vitro. Histochemistry and Cell Biology. 149(3). 219–233. 32 indexed citations

15.

Bhat, Jaydeep, Johannes Helmuth, Guranda Chitadze, et al.. (2017). Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T‐Cell Differentiation and Functional Plasticity. Scandinavian Journal of Immunology. 86(4). 184–195. 5 indexed citations

16.

Chitadze, Guranda, Hans‐Heinrich Oberg, Daniela Wesch, & Dieter Kabelitz. (2017). The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity. Trends in Immunology. 38(9). 668–678. 68 indexed citations

17.

Chitadze, Guranda, Marcus Lettau, Stefanie Luecke, et al.. (2015). NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors. OncoImmunology. 5(4). e1093276–e1093276. 59 indexed citations

18.

Chitadze, Guranda, et al.. (2014). Intracellular pathways following uptake of bevacizumab in RPE cells. Experimental Eye Research. 131. 29–41. 32 indexed citations

19.

Chitadze, Guranda, Jaydeep Bhat, Marcus Lettau, Ottmar Janßen, & Dieter Kabelitz. (2013). Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications. Scandinavian Journal of Immunology. 78(2). 120–129. 144 indexed citations

20.

Chitadze, Guranda, et al.. (1981). Thermal properties of intact nucleoproteides. Journal of Polymer Science Polymer Symposia. 69(1). 17–20. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact